Insiders at three major US companies have filed over $1 billion in combined sales in recent weeks, with AI infrastructure and healthcare names leading the charge.
At CRWV, hedge fund Magnetar Financial filed sales of more than $909 million in CoreWeave shares between May 1 and May 14. The 10% owner sold across multiple days, offloading hundreds of thousands of shares as the newly public AI cloud company's stock climbed following its March IPO.
CVS saw a board-linked hedge fund, Glenview Capital's Larry Robbins, file $326 million in sales this week alone. Filings submitted May 21 showed trades on May 19–21 totalling nearly 3.4 million shares at roughly $94 each. CVS's CTO Tilak Mandadi also filed a $6.2 million sale on May 11.
At MPWR, Monolithic Power Systems CEO and founder Michael Hsing filed sales of over $45 million on May 20, with trades executed May 18. Executive VP Deming Xiao filed an additional $48 million in sales earlier in May. Six insiders sold a combined $130 million — a notable cluster as the chipmaker trades near all-time highs.
On the buying side, Capital Group filed a $285 million stake increase in ONC, oncology company BeOne Medicines, with the trade reported May 22. That signals institutional confidence in the biotech's pipeline.
This article is not financial advice.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
